Cancer Treatment Reviews
Volume 35, Issue 8 , Pages 662-667, December 2009

The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients

  • Catherine Oakman

      Affiliations

    • These authors have contributed equally to this manuscript.
    • ,
  • Erica Moretti

      Affiliations

    • These authors have contributed equally to this manuscript.
    • ,
  • Francesca Galardi
    • ,
  • Libero Santarpia
    • ,
  • Angelo Di Leo

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: ‘Sandro Pitigliani’ Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100 Prato, Italy. Tel.: +39 0574 434766; fax: +39 0574 29798.

Translational Research Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100 Prato, Italy

Received 12 June 2009; received in revised form 6 August 2009; accepted 7 August 2009. published online 16 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(09)00121-2

doi:10.1016/j.ctrv.2009.08.006

Cancer Treatment Reviews
Volume 35, Issue 8 , Pages 662-667, December 2009

Article Tools

* Image Usage & Resolution